Menopause Affects Women Differently

Menopause Affects Women Differently.
Women bothered by popular flashes or other property of menopause have a number of treatment options - hormonal or not, according to updated guidelines from the American College of Obstetricians and Gynecologists. It's estimated that anywhere from 50 percent to 82 percent of women succeeding through menopause have unpredictable flashes - sudden feelings of extreme eagerness in the upper body - and night sweats. For many, the symptoms are frequent and severe enough to cause drop problems and disrupt their daily lives.

And the duration of the misery can last from a couple years to more than a decade, says the college, the nation's influential group of ob/gyns. "Menopausal symptoms are common, and can be very bothersome to women," said Dr Clarisa Gracia, who helped make out the new guidelines. "Women should recognize that effective treatments are available to address these symptoms". The guidelines, published in the January consummation of Obstetrics andamp; Gynecology, reinforce some longstanding advice: Hormone therapy, with estrogen tout or estrogen plus progestin, is the most effective way to cool hot flashes.

But they also set out out the growing evidence that some antidepressants can help an associate professor of obstetrics and gynecology at the University of Pennsylvania in Philadelphia. In studies, muffled doses of antidepressants such as venlafaxine (Effexor) and fluoxetine (Prozac) have helped palliate hot flashes in some women. And two other drugs - the anti-seizure medicament gabapentin and the blood pressure medication clonidine - can be effective, according to the guidelines.

So far, though, only one non-hormonal sedate is actually approved by the US Food and Drug Administration for treating fervent flashes: a low-dose version of the antidepressant paroxetine (Paxil). And experts said that while there is proof some hormone alternatives ease hot flashes, none works as well as estrogen and estrogen-progestin. "Unfortunately, many providers are fearful to prescribe hormones.

And a lot of the time, women are fearful," said Dr Patricia Sulak, an ob/gyn at Scott andamp; White Hospital in Temple, Texas, who was not convoluted in calligraphy the new guidelines. Years ago, doctors routinely prescribed hormone replacement remedy after menopause to lower women's risk of heart disease, among other things. But in 2002, a liberal US trial called the Women's Health Initiative found that women given estrogen-progestin pills in fact had slightly increased risks of blood clots, heart attack and breast cancer. "Use of hormones plummeted" after that.

Some Postmenopausal Women From Breast Cancer Can Protect Hormonal Therapy

Some Postmenopausal Women From Breast Cancer Can Protect Hormonal Therapy.
In a find that seems to marker the prevailing wisdom that any form of hormone replacement psychoanalysis raises the risk of breast cancer, a new look at some old data suggests that estrogen-only hormone group therapy might protect a small subset of postmenopausal women against the disease. "Exogenous estrogen such as hormone analysis is actually protective" in women who have a low risk for developing tit tumors, said study author Dr Joseph Ragaz, a medical oncologist and clinical professor in the School of Population & Public Health at the University of British Columbia in Vancouver. With his colleagues, Ragaz took another manner at details from the Women's Health Initiative (WHI) study, a jingoistic trial that has focused on ways to prevent breast and colorectal cancer, as well as sentiment disease and fracture risk, in postmenopausal women.

The team planned to present its findings Thursday at the San Antonio Breast Cancer Symposium in Texas. Research presented at medical meetings is not analyzed by home experts, ill-matched studies that appear in peer-reviewed medical journals, and all such findings should be considered preliminary. Launched in 1991, the WHI includes more than 161000 US women between the ages of 50 and 79.

Two groups were area of the thorn in the flesh - women who had had hysterectomies and took estrogen desolate as hormone replacement therapy and a group that took estrogen plus progestin hormone replacement therapy. The mix therapy trial was halted in 2002 after it became clear those women were at increased chance for heart disease and breast cancer.

In the new look at the estrogen-only group "we looked at women who did not have high-risk features". They found that women with no earlier history of benign teat disease had a 43 percent reduction breast cancer risk on estrogen; women with no house history with a first-degree relative with breast cancer had a 32 percent risk reduction and women without past hormone use had a 32 percent reduced risk.

Reduction The Hormone Estrogen Leads To Mental Decline.
The younger a helpmate is when she undergoes surgical menopause, the greater her chances of developing respect problems at an earlier age, young digging suggests. Surgical menopause describes the end of ovarian banquet due to gynecological surgery before the age of appropriate menopause. It involves the removal of one or both ovaries (an oophorectomy), often in conspiracy with a hysterectomy, the removal of a woman's uterus skin care. "For women with surgically induced menopause, old age at menopause was associated with a faster deterioration in memory," said work author Dr Riley Bove, an instructor in neurology at Harvard Medical School and an fellow neurologist at Brigham and Women's Hospital in Boston.

However, she stressed, "These are very antecedent data". Bove said other analysis suggests a link between a decrease in the hormone estrogen during menopause and balmy decline, and the aim of this study was to better understand the relation between reproductive-health factors and memory changes. The lucubrate results will be presented in March at the American Academy of Neurology' annual meeting, in San Diego.

For the study, the researchers analyzed medical records of more than 1800 women old 53 to 100 who were winning voice in one of two studies conducted by Rush University Medical Center in Chicago: the Religious Orders Study and the Memory and Aging Project. The researchers assessed reproductive variables, such as when women had their in front period, the numbers of years menstrual cycles lasted, and use of hormone replacement therapies. Measurements from several types of ratiocinative and celebration tests were analyzed, too.

The scientists also assessed the results of mastermind biopsies after death, some of which showed the company of Alzheimer's plaques. "We had approximately 580 brains ready for analysis - this speaks to the very lone and rich nature of the data," said Bove. Thirty-three percent of the cram participants had undergone surgical menopause.

Reasons for these surgeries may incorporate fibroids (noncancerous uterine tumors), endometriosis (growth of uterine network outside the womb), cancer of the uterus and ovaries, and deviant vaginal bleeding. When the ovaries are gone, ovarian result of estrogen stops, said Bove. However, this deliberate over did not include reasons why the women underwent surgical menopause.